These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
79 related articles for article (PubMed ID: 14986763)
41. The sex kitten of bioethics? Research ethics comes of age. Resink DB Hastings Cent Rep; 2008; 38(5):5-6. PubMed ID: 18949856 [No Abstract] [Full Text] [Related]
42. In the face of death: four ethical issues. Ozar DT Perspectives Prof; 2000; 20(1):E6. PubMed ID: 15115043 [No Abstract] [Full Text] [Related]
44. [What happened on March 13th at the Northwick Park Hospital in London?]. Nau JY Rev Med Suisse; 2006 Apr; 2(63):1133. PubMed ID: 16711457 [No Abstract] [Full Text] [Related]
45. Towards a reasons-based pragmatic ethical framework. Viens AM Am J Bioeth; 2008 Apr; 8(4):41-3. PubMed ID: 18576254 [No Abstract] [Full Text] [Related]
46. Deprivation, disease, and the ethics of international research. London A Bioeth Exam; 2000; 4(1):1, 4. PubMed ID: 14746326 [No Abstract] [Full Text] [Related]
47. Justice in the application of science: beyond fair benefits. London AJ Am J Bioeth; 2010 Jun; 10(6):54-6. PubMed ID: 20526976 [No Abstract] [Full Text] [Related]
48. Multiple forms of exploitation in international research: the need for multiple standards of fairness. Snyder J Am J Bioeth; 2010 Jun; 10(6):40-1. PubMed ID: 20526969 [No Abstract] [Full Text] [Related]
49. Fair benefits in developing countries: maximin as a good start. Macklin R Am J Bioeth; 2010 Jun; 10(6):36-7. PubMed ID: 20526967 [No Abstract] [Full Text] [Related]
50. Cancer research and therapy: a view from Norway. Ruyter KW Perspectives Prof; 2000; 20(1):E5. PubMed ID: 15115042 [No Abstract] [Full Text] [Related]
51. Travelling bioethics. ten Have H; Gordijn B Med Health Care Philos; 2011 Feb; 14(1):1-3. PubMed ID: 21086052 [No Abstract] [Full Text] [Related]
52. Placebos in clinical trials: new forms of an old issue. Brody BA Health Law News; 2000 Jun; 13(3):4, 14. PubMed ID: 12542041 [No Abstract] [Full Text] [Related]
53. Reversing "research exceptionalism". Hansson SO Am J Bioeth; 2010 Aug; 10(8):66-7. PubMed ID: 20694917 [No Abstract] [Full Text] [Related]
54. Beyond research exceptionalism: a call for process redesign. Bean S Am J Bioeth; 2010 Aug; 10(8):58-60. PubMed ID: 20694912 [No Abstract] [Full Text] [Related]
55. Protection of research subjects. Berger JT N Engl J Med; 2003 Jul; 349(2):188-92; author reply 188-92. PubMed ID: 12856647 [No Abstract] [Full Text] [Related]
56. Explicit declaration of ethical approval for clinical research. Eastwood GM Aust Crit Care; 2011 May; 24(2):89. PubMed ID: 21546261 [No Abstract] [Full Text] [Related]
57. Is risky pediatric research without prospect of direct benefit ever justified? Martin RA; Robert JS Am J Bioeth; 2007 Mar; 7(3):12-5. PubMed ID: 17366221 [No Abstract] [Full Text] [Related]
58. Is pragmatism just an apology for unrestrained science? Spriggs M Am J Bioeth; 2008 Apr; 8(4):39-41. PubMed ID: 18576253 [No Abstract] [Full Text] [Related]
59. Testing medications in children. Steinbrook R N Engl J Med; 2002 Oct; 347(18):1462-70. PubMed ID: 12409558 [No Abstract] [Full Text] [Related]
60. Response to open peer commentaries on "Social contexts influence ethical considerations of research". Levine RJ; Gordon JB; Mazure CM; Rubin PE; Schaller BR; Young JL Am J Bioeth; 2011 May; 11(5):W1-2. PubMed ID: 21534134 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]